Safety and efficacy of combination therapy (Simeprevir/Sofosbuvir) in the treatment of chronic HCV genotype IV patients
Chronic infection with HCV is a worldwide health problem that may lead to cirrhosis, portal hypertension, hepatocellular failure and hepatocellular carcinoma in most of cases. A new era in HCV treatment has been started using direct acting antiviral activity. In this study we assess the safety and e...
Main Authors: | Engy A. Wahsh, Amal K. Hussein, Ahmed A. Gomaa, Mohamed A. Baraka, Mohie Al-deen Abead |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2018-03-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=272628 |
Similar Items
-
The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir
by: Walker DR, et al.
Published: (2015-12-01) -
Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms
by: Essam Ezzeldin, et al.
Published: (2020-10-01) -
Successful Treatment Using Simeprevir, Sofosbuvir and Rituximab of a Severe Form of Hepatitis C Virus-related Mixed Cryoglobulinemia with Cardiac Involvement
by: Rafael Mahieu, et al.
Published: (2015-11-01) -
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort
by: Anne Laurain, et al.
Published: (2019-04-01) -
Remission of long-term hepatic and renal disease induced by HCV after direct-acting antivirals therapy
by: Raissa M Arruda, et al.
Published: (2020-10-01)